These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12216542)

  • 21. Schnitzler Syndrome: a Review.
    Gusdorf L; Lipsker D
    Curr Rheumatol Rep; 2017 Aug; 19(8):46. PubMed ID: 28718061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptomatic treatment of a case of Schnitzler's syndrome with pamidronate.
    Wendling D; Prati C; Hoen B; Toussirot E; Streit G; Dumoulin G
    Joint Bone Spine; 2008 Jul; 75(4):507-8. PubMed ID: 18486515
    [No Abstract]   [Full Text] [Related]  

  • 23. Schnitzler's syndrome: what's new?
    Almerigogna F; Giudizi MG; Cappelli F; Romagnani S
    J Eur Acad Dermatol Venereol; 2002 May; 16(3):214-9. PubMed ID: 12195558
    [No Abstract]   [Full Text] [Related]  

  • 24. The Schnitzler syndrome: chronic urticaria in disguise: a single-centre report of 11 cases and a critical reappraisal of the literature.
    Vanderschueren S; van der Veen A
    Clin Exp Rheumatol; 2017; 35(1):69-73. PubMed ID: 27606610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic vasculitis urticaria associated to a monoclonal gammopathy of IgM and IgA type, a Schnitzler Syndrome?
    Carlesimo M; Abruzzese C; Narcisi A; La Verde G; De Marco G; Verga E; Fidanza L; Camplone G
    Eur J Dermatol; 2010; 20(6):838-9. PubMed ID: 20956107
    [No Abstract]   [Full Text] [Related]  

  • 26. Dermal interleukin-1 expression and effective and long-lasting therapy with interleukin-1 receptor antagonist anakinra in Schnitzler syndrome.
    Volz T; Wölbing F; Fischer J; Braun M; Maggoschitz I; Schaller M; Berneburg M; Biedermann T
    Acta Derm Venereol; 2012 Jul; 92(4):393-4. PubMed ID: 22334118
    [No Abstract]   [Full Text] [Related]  

  • 27. Chronic urticaria with monoclonal IgG gammopathy: a clinical variant of Schnitzler syndrome?
    Patel S; Sindher S; Jariwala S; Hudes G
    Ann Allergy Asthma Immunol; 2012 Aug; 109(2):147-8. PubMed ID: 22840258
    [No Abstract]   [Full Text] [Related]  

  • 28. Effectiveness of anti-IL1 in Schnitzler's syndrome.
    Klemmer N; Lenain P; Balguerie X; Le Loët X
    Joint Bone Spine; 2007 Oct; 74(5):509-10. PubMed ID: 17921021
    [No Abstract]   [Full Text] [Related]  

  • 29. [Translated article] Schnitzler Syndrome, and the MEFV Gene Variant.
    Nicolás-Sánchez FJ; Aróstegui-Gorospe JI; Tarragona-Foradada J; González-Barranquero A
    Actas Dermosifiliogr; 2024; 115(7):T744-T745. PubMed ID: 38815681
    [No Abstract]   [Full Text] [Related]  

  • 30. Schnitzler Syndrome Without a Monoclonal Gammopathy: A Case Report.
    Urbanski M; Holfeld K; Milne A; Abbas M
    J Cutan Med Surg; 2016 Nov; 20(6):575-578. PubMed ID: 27358310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schnitzler Syndrome after COVID-19 Vaccination.
    Asako M; Matsunaga H; Oka K; Ueda S
    Intern Med; 2022 Aug; 61(15):2397. PubMed ID: 35650133
    [No Abstract]   [Full Text] [Related]  

  • 32. Intracostal neuralgia as a previously undescribed symptom of Schnitzler's syndrome.
    Lee KY; Grattan CE
    Br J Dermatol; 2012 Dec; 167(6):1392-3. PubMed ID: 22591057
    [No Abstract]   [Full Text] [Related]  

  • 33. [Schnitzler syndrome: case report, the experience with glucocorticoid and anakinra (Kineret) therapies and monitoring of systemic cytokine response].
    Szturz P; Adam Z; Klabusay M; Fojtík Z; Kadanka Z; Stehlíková O; Chovancová J; Kalvodová L; Corbová D; Starý K; Neubauer J; Prásek J; Koukalová R; Rehák Z; Hájek R; Mayer J
    Vnitr Lek; 2011 Jan; 57(1):97-112. PubMed ID: 21351669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tocilizumab treatment in patients with Schnitzler syndrome: An open-label study.
    Bonnekoh H; Frischbutter S; Roll S; Maurer M; Krause K
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2486-2489.e4. PubMed ID: 33545397
    [No Abstract]   [Full Text] [Related]  

  • 35. Schnitzler syndrome: response to anakinra in two cases and a review of the literature.
    Schuster C; Kränke B; Aberer E; Arbab E; Sturm G; Aberer W
    Int J Dermatol; 2009 Nov; 48(11):1190-4. PubMed ID: 20064173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schnitzler syndrome-An underdiagnosed adult-onset autoinflammatory disease.
    Chu CQ
    Int J Rheum Dis; 2024 Jan; 27(1):e14925. PubMed ID: 37737513
    [No Abstract]   [Full Text] [Related]  

  • 37. Delayed development of the IgM paraprotein in Schnitzler's syndrome.
    Mulla E; Neame R
    Scand J Rheumatol; 2015; 44(6):521-2. PubMed ID: 26395927
    [No Abstract]   [Full Text] [Related]  

  • 38. Can therapeutic response to IL-1 blockade confirm the diagnosis of Schnitzler syndrome?
    Wang C
    Clin Rheumatol; 2021 Feb; 40(2):805. PubMed ID: 33428102
    [No Abstract]   [Full Text] [Related]  

  • 39. Striking effect of the IL-1 receptor antagonist anakinra in chronic urticarial rash with polyclonal increase in IgA and IgG.
    Treudler R; Kauer F; Simon JC
    Acta Derm Venereol; 2007; 87(3):280-1. PubMed ID: 17533504
    [No Abstract]   [Full Text] [Related]  

  • 40. Schnitzler syndrome: a dramatic improvement with anakinra.
    Wastiaux H; Barbarot S; Gagey-Caron V; Berthelot JM; Hamidou M; Stalder JF
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):85-7. PubMed ID: 18355191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.